tryptophan has been researched along with Tuberous Sclerosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, E; Bagla, S; Chugani, DC; Chugani, HT; Cukovic, D; Dombkowski, AA; Luat, A; Sood, S | 1 |
| Asano, E; Chugani, HT; Govindan, R; Kumar, A; Luat, AF; Pawlik, K | 1 |
| Bouvard, S; Catenoix, H; Costes, N; Hammers, A; Heckemann, RA; Hino, K; Jung, J; Le Bars, D; Liger, F; Martí Fuster, B; Montavont, A; Ostrowsky, K; Rubí, S; Ryvlin, P; Setoain, X | 1 |
| Asano, E; Chugani, HT; Kumar, A | 1 |
| Chakraborty, PK; Chugani, HT; Kumar, A; Tiwari, VN | 1 |
| Andermann, E; Andermann, F; Boling, W; Diksic, M; Dubeau, F; Fedi, M; Gross, DW; Nakai, A; Okazawa, H; Reutens, DC; White, C | 1 |
| Asano, E; Chakraborty, PK; Chugani, DC; Chugani, HT; Juhász, C; Kagawa, K; Kupsky, WJ; Mangner, TJ; Muzik, O; Shah, A; Shah, J; Sood, S | 1 |
| Au, KS; Harris, PC; Northrup, H; Williams, AT; Woerner, AC | 1 |
| Canady, A; Chakraborty, PK; Chugani, DC; Chugani, HT; Mangner, TJ; Muzik, O; Shah, AK; Shah, JR | 1 |
| Chugani, DC; Chugani, HT | 1 |
| Asano, E; Behen, M; Chakraborty, PK; Chugani, DC; Chugani, HT; Janisse, J; Mangner, TJ; Muzik, O; Rothermel, R | 1 |
| Breakey, WR | 1 |
2 review(s) available for tryptophan and Tuberous Sclerosis
| Article | Year |
|---|---|
α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies.
Topics: Biomarkers; Brain; Epilepsy; Humans; Positron-Emission Tomography; Tryptophan; Tuberous Sclerosis | 2011 |
PET: mapping of serotonin synthesis.
Topics: Adolescent; Brain; Child; Child, Preschool; Epilepsies, Partial; Female; Humans; Infant; Serotonin; Tomography, Emission-Computed; Tryptophan; Tuberous Sclerosis | 2000 |
10 other study(ies) available for tryptophan and Tuberous Sclerosis
| Article | Year |
|---|---|
A distinct microRNA expression profile is associated with α[
Topics: Child; Child, Preschool; Female; Gene Expression; Gene Expression Profiling; Humans; Infant; Male; MicroRNAs; Positron-Emission Tomography; Seizures; Symporters; Tryptophan; Tuberous Sclerosis | 2018 |
α-[11C]-Methyl-L-tryptophan--PET in 191 patients with tuberous sclerosis complex.
Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Child; Child, Preschool; Female; Humans; Infant; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tryptophan; Tuberous Sclerosis; Young Adult | 2013 |
Positron emission tomography with α-[11C]methyl-L-tryptophan in tuberous sclerosis complex-related epilepsy.
Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Child; Child, Preschool; Electroencephalography; Epilepsy; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Tryptophan; Tuberous Sclerosis; Young Adult | 2013 |
Can diffusion tensor imaging (DTI) identify epileptogenic tubers in tuberous sclerosis complex? Correlation with α-[11C]methyl-L-tryptophan ([11C] AMT) positron emission tomography (PET).
Topics: Adolescent; Anisotropy; Carbon Radioisotopes; Cerebral Cortex; Child; Child, Preschool; Diffusion Tensor Imaging; Epilepsy; Female; Humans; Male; Positron-Emission Tomography; Statistics as Topic; Tryptophan; Tuberous Sclerosis | 2012 |
alpha-[11C]-Methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency.
Topics: Adolescent; Adult; Carbon Radioisotopes; Child, Preschool; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Seizures; Tomography, Emission-Computed; Tryptophan; Tuberous Sclerosis | 2003 |
Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET).
Topics: Carbon Radioisotopes; Child; Child, Preschool; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Infant; Male; Positron-Emission Tomography; Reproducibility of Results; Treatment Outcome; Tryptophan; Tuberous Sclerosis | 2005 |
Tuberous sclerosis complex and polycystic kidney disease together: an exception to the contiguous gene syndrome.
Topics: Amino Acid Substitution; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 4; Chromosomes, Human, Pair 9; Female; Gene Deletion; Gene Frequency; Genes, Dominant; Genetic Linkage; Genetic Markers; Humans; Incidence; Male; Membrane Proteins; Mutation, Missense; Pedigree; Penetrance; Polycystic Kidney Diseases; Proteins; Sequence Analysis, DNA; Severity of Illness Index; TRPP Cation Channels; Tryptophan; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2006 |
Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography.
Topics: Brain; Carbon Radioisotopes; Child; Electroencephalography; Epilepsy; Female; Humans; Magnetic Resonance Imaging; Male; Tomography, Emission-Computed; Tryptophan; Tuberous Sclerosis | 1998 |
Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction.
Topics: Adolescent; Autistic Disorder; Carbon Radioisotopes; Cerebellar Nuclei; Cerebral Cortex; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glucose; Humans; Infant; Male; Radiopharmaceuticals; Spasms, Infantile; Tomography, Emission-Computed; Tryptophan; Tuberous Sclerosis | 2001 |
Tryptophan loading in tuberous sclerosis.
Topics: Adolescent; Adult; Anticonvulsants; Body Weight; Epilepsy; Female; Humans; Intellectual Disability; Male; Middle Aged; Pyridoxine; Tryptophan; Tuberous Sclerosis; Xanthurenates | 1969 |